Protective effect of the combinations of glycyrrhizic, Ferulic and cinnamic acid pretreatment on myocardial ischemia-reperfusion injury in rats

Experimental and Therapeutic Medicine

Volumn 9, Issue 2, 2015, Pages 435-445

  Gao, Yuqin ^a,b   Hao, Jiping ^a   Zhang, Hongkao ^c   Qian, Guoqiang ^d   Jiang, Renwang ^e   Zhao, Guoping ^b   Wang, Jianing ^e   Lei, Zhang ^e   Hu, Jing ^b  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b MEDICAL COLLEGE OF JINAN UNIVERSITY   (China)

^c HUANGHUAI UNIVERSITY   (China)

^d JINAN UNIVERSITY   (China)

^e HUBEI UNIVERSITY OF MEDICINE   (China)

Author keywords

Cinnamic acid; Ferulic acid; Glycyrrhizic acid; Ischemia reperfusion cocktail

Indexed keywords

CINNAMIC ACID; CREATINE KINASE MB; DANG GUI SI NI TANG DECOCTION; FERULIC ACID; GLYCYRRHIZIC ACID; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; MALONALDEHYDE; PAEONIFLORIN; PLANT MEDICINAL PRODUCT; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DRUG ABSORPTION; ELECTRON MICROSCOPY; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOLOGY; MALE; NONHUMAN; RAT; REPERFUSION INJURY; WESTERN BLOTTING;

EID: 84918796503     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2014.2134     Document Type: Article

References (47)

1. Murray CJ and Lopez AD: Alternative projection of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 349: 1498-1504, 1997.
2. Yellon DM and Hausenloy DJ: Myocardial reperfusion injury. N Engl J Med 357: 1121-1135, 2007.
3. Murry CE, Jennings RB and Reimer KA: Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74: 1124-1136, 1986.
4. Philipp S, Yang XM, Cui L, et al: Postconditioning protects rabbit hearts through a protein kinase C-adenosine A2b receptor casade. Cardiovasc Res 70: 308-314, 2006.
5. Tissier R, Cohen MV and Downey JM: Protecting the acutely ischemic myocardium beyond reperfusion therapies: are we any closer to realizing the dream of infarct size elimination? Arch Mal Coeur Vaiss 100: 794-802, 2007.
6. Gross ER, Hsu AK and Gross GJ: Opioid-induced cardioprotection occurs via glycogen synthase kinase beta inhibition during reperfusion in intact rat hearts. Circ Res 94: 960-966, 2004.
7. Tissier R, Waintraub X, Couvreur N et al: Pharmacological postconditioning with the phytoestrogen genistein. J Mol Cell Cardiol 42: 79-87, 2007.
8. Efthymiou CA, Mocanu MM and Yellon DM: Atorvastatin and myocardial reperfusion injury: new pleiotropic effect implicating multiple prosurvival signaling. J Cardiovasc Pharmacol 45: 247-252, 2005.
9. Gao YQ, Zhao GP and Jiang RW: Determination of ferulic acid serum concentration in Danggui Sini Decotion by HPLC and its pharmacokinetics in rats. Zhong Cheng Yao 33: 419-422, 2011 (In Chinese).
10. Gao YQ, Wu J, Jiang RW and Zhao GP: Determination of cinnamic acid and glycyrrhizic acid in rat serum and its pharmacokinetics after oral administration of Dangguisini decoction. Zhong Yao Cai 34: 408-411, 2011 (In Chinese).
11. Zhao X, Gu Y, Song XX, et al: Simultaneous determination of four main components in Dangguisini decoction. Shenyang Yao Ke Da Xue Xue Bao 13: 200-203, 2008 (In Chinese).
12. Nagai T, Egashira T, Yamanaka Y and Kohno M: The protective effect of glycyrrhizin against injury of the liver caused by ischemia-reperfusion. Arch Environ Contam Toxicol 20: 432-436, 1991.
13. Abdugafurova MA, Li VS, et al: Antioxidative properties of glycyrrhyzic acid salts and their effect on the liver monooxygenase system. Vopr Med Khim 36: 29-31, 1990 (In Russian).
14. Yokozawa T, Liu ZW and Chen CP: Protective effects of Glycyrrhizae radix extract and its compounds in a renal hypoxia (ischemia)-reoxygenation (reperfusion) model. Phytomedicine 6: 439-445, 2000.
15. Kilgore KS, Tanhehco EJ, Park JL et al: Reduction of myocardial infarct size in vivo by carbohydrate-based glycomimetics. J Pharmacol Exp Ther 284: 427-435, 1998.
16. Nagai T, Egashira T, Kudo Y, Yamanaka Y and Shimada T: Attenuation of dysfunction in the ischemia-reperfused liver by glycyrrhizin. Jpn J Pharmacol 58: 209-218, 1992.
17. Cartron E, Carbonneau MA, et al: Specific antioxidant activity of caffeoyl derivatives and other natural phenolic compounds: LDL protection against oxidation and decrease in the proinflammatory lysophosphatidylcholine production. J Nat Prod 64: 480-486, 2001.
18. Banskota AH, Nagaoka T, Sumioka LY, et al: Antiproliferative activity of the Netherlands propolis and its active principles in cancer cell lines. J Ethnopharmacol 80: 67-73, 2002.
19. Neto CC: Cranberry and blueberry: evidence for protective effects against cancer and vascular diseases. Mol Nutr Food Res 51: 652-664, 2007.
20. Huang X, Qin F, Zhang HM, et al: Cardioprotection by Guanxin II in rats with acute myocardial infarction is related to its three compounds. J Ethnopharmacol 121: 268-273, 2009.
21. Yogeeta SK, Raghavendran HR, Gnanapragasam A, et al: Ferulic acid with ascorbic acid synergistically extenuates the mitochondrial dysfunction during beta-adrenergic catecholamine induced cardiotoxicity in rats. Chem Biol Interact 163: 160-169, 2006.
22. Wolfrum S, Richardt G, Dominiak P et al: Apstatin, a selective inhibitor of aminopeptidase P, reduces myocardial infarct size by a kinin-dependent pathway. Br J Pharmacol 134: 370-374, 2001.
23. Murota S, Fujita H, Wakabayashi Y and Morita I: Cell adhesion molecule mediates endothelial cell injury caused by activated neutrophils. Keio J Med 45: 207-211, 1996.
24. López-Cacho JM, González-R PL, et al: Robust optimization of alginate-Carbopol 940 bead formulations. ScientificWorldJournal 2012: 605610, 2012.
25. Zhou J, Sun JB, Zheng P, et al: Orthogonal array design for optimization of hollow-fiber-based liquid-phase microextraction combined with high-performance liquid chromatography for study of the pharmacokinetics of magnoflorine in rat plasma. Anal Bioanal Chem 403: 1951-1960, 2012.
26. Xu Y, Zhang Y, Li Y, et al: Growth promotion of Yunnan pine early seedlings in response to foliar application of IAA and IBA. Int J Mol Sci 13: 6507-6520, 2012.
27. Cerqueira NF, Hussni CA and Yoshida WB: Pathophysiology of mesenteric ischemia/reperfusion: a review. Acta Cir Bras 20: 336-343, 2005.
28. Burley DS, Ferdinandy P and Baxter GF: Cyclic GMP and protein kinase-G in myocardial ischaemia-reperfusion: opportunities and obstacles for survival signaling. Br J Pharmacol 152: 855-869, 2007.
29. Chen HP, Liao ZP, Huang QR and He M: Sodium ferulate attenuates anoxia/reoxygenation-induced calcium overload in neonatal rat cardiomyocytes by NO/cGMP/PKG pathway. Eur J Pharmacol 603: 86-92, 2009.
30. Howes MJ, Perry NS and Houghton PJ: Plants with traditional uses and activities, relevant to the management of Alzheimer's disease and other cognitive disorders. Phytother Res 17: 1-18, 2003.
31. Point D, Coudert P, Leal F, et al: Antioxidant activity of some ascorbic and cinnamic acids derivatives. Farmaco 53: 85-88, 1998.
32. Jeong HG, You HJ, Park SJ, et al: Hepatoprotective effects of 18beta-glycyrrhetinic acid on carbon tetrachloride-induced liver injury: inhibition of cytochrome P450 2E1 expression. Pharmacol Res 46: 221-227, 2002.
33. Jaeschke H: Mechanisms of liver injury. II. Mechanisms of neutrophil-induced liver cell injury during hepatic ischemia-reperfusion and other acute inflammatory conditions. Am J Physiol Gastrointest Liver Physiol 290: G1083-G1088, 2006.
34. Spanos CP, Papaconstantinou P, Spanos P, et al: The effect of L-arginine and aprotinin on intestinal ischemia-reperfusion injury. J Gastrointest Surg 11: 247-255, 2007.
35. Sima N, Lü W and Xie X: Early proteins E6 and E7 of human papillomavirus may attenuate ischemia-reperfusion injury. Med Hypotheses 76: 607-609, 2011.
36. Olanders K, Sun Z, Börjesson A et al: The effect of intestinal ischemia and reperfusion injury on ICAM-1 expression, endothelial barrier function, neutrophil tissue influx, and protease inhibitor levels in rats. Shock 18: 86-92, 2002.
37. Venardos KM, Perkins A, Headrick J and Kaye DM: Myocardial ischemia-reperfusion injury, antioxidant enzyme systems and selenium: a review. Curr Med Chem 14: 1539-1549, 2007.
38. Di Paola R, Menegazzi M, Mazzon E, et al: Protective effects of glycyrrhizin in a gut hypoxia (ischemia)-reoxygenation (reperfusion) model. Intensive Care Med 35: 687-697, 2009.
39. Cepinskas G, Rui T and Kvietys PR: Interaction between reactive oxygen metabolites and nitric oxide in oxidant tolerance. Free Radic Biol Med 33: 433-440, 2002.
40. Li C, Browder W and Kao RL: Early activation of transcription factor NF-kappaB during ischemia in perfused rat heart. Am J Physiol 276: H543-H552, 1999.
41. Inoue I, Goto S, Matsunaga T, et al: The ligands/activators for peroxisome proliferator-activated receptor alpha (PPARalpha) and PPARgamma increase Cu2+, Zn2+-superoxide dismutase and decrease p22phox message expressions in primary endothelial cells. Metabolism 50: 3-11, 2001.
42. Yoo HY, Chang MS and Rho HM: Induction of the rat Cu/Zn superoxide dismutase gene through the peroxisome proliferator-responsive element by arachidonic acid. Gene 234: 87-91, 1999.
43. Ding GL, Cheng L, et al: PPARdelta modulates lipopolysaccharide-induced TNFalpha inflammation signaling in cultured cardiomyocytes. J Mol Cell Cardiol 40: 821-828, 2006.
44. Inoue I, Noji S, Awata T, et al: Bezafibrate has an antioxidant effect: peroxisome proliferator-activated receptor alpha is associated with Cu2+, Zn2+-superoxide dismutase in the liver. Life Sci 63: 135-144, 1998.
45. Marx N, Duez H, Fruchart JC and Staels B: Peroxisome proliferator-activated receptors and atherogenesis: regulators of gene expression in vascular cells. Circ Res 94: 1168-1178, 2004.
46. Marx N, Sukhova GK, et al: PPARalpha activators inhibit cytokine-induced vascular cell adhesion molecule-1 expression in human endothelial cells. Circulation 99: 3125-3131, 1999.
47. Bulhak AA, Jung C, Ostenson CG, et al: PPARalpha activation protects the type 2 diabetic myocardium against ischemia-reperfusion injury: involvement of the PI3-Kinase/Akt and NO pathway. Am J Physiol Heart Circ Physiol 296: H719-H727, 2009.